GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

01 Jul 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF), has purchased 5233 equity shares aggregating to Rs. 487917.62/- from 05.06.2023 to 30.06.2023, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations 2015. However, as a good Corporate Governance Measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta & Sons(HUF). Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

30 Jun 2023

69.80

-0.11%

SAST

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI(Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the "Trading Window" for dealing/trading in the shares of the Company shall remain closed from July 01, 2023, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter ended June 30, 2023. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board Meeting t which the said results will be considered, shall be intimated in due course of time. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

14 Jun 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Intimation Under Regulation 30 Of SEBI ( Listing Obligations And …

BSE India

Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company vide Circular Resolution passed on June 13, 2023, has appointed Mr. Purushottam S. Mantri (DIN:06785989) as an Additional Director ( Non- Executive & Independent ) w.e.f. June 20, 2023, for a period of five consecutive years subject to the approval of the members in the forthcoming Annual General Meeting. Mr. Purushottam S. Mantri is not related to any of the Directors of the Company. Further, in accordance with the circular dated June 20, 2018 issued by the stock exchanges, we hereby confirm that Mr. Purushottam S. Mantri is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

02 Jun 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached copies of newspaper cuttings of the extract of Statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2023, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated June 01, 2023. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

01 Jun 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Dispatch Of KYC, Nomination Details And Forms To Physical Shareholders …

BSE India

Pursuant to Regulation 30 and Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that pursuant to the Securities and Exchange Board of India (SEBI) Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated March 16, 2023, our RTA- Link Intime India Pvt Ltd., has completed the dispatch of letters intimating the shareholders holding shares in physical mode, regarding mandatory furnishing of PAN, KYC details and Nomination. This is for your information and records.

pdf

GKB Ophthalmics Ltd.

31 May 2023

69.80

-0.11%

Annual Report

Annual report for GKB Ophthalmics Ltd. for FY-2023

None

pdf

GKB Ophthalmics Ltd.

30 May 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Submission Of Consolidated Related Party Transactions As On March 31, …

BSE India

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a disclosure on Related Party Transaction on consolidated basis for the half year ended March 31, 2023. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

30 May 2023

69.80

-0.11%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB …

BSE India

The meeting of the Board of Directors of the Company was held on May 30, 2023, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter and year ended March 31, 2023, together with Auditors'' Report. 2. Consolidated Financial Results for the quarter and year ended March 31, 2023, along with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2023, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors'' Reports'' are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com.

pdf

GKB Ophthalmics Ltd.

30 May 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI …

BSE India

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on May 30, 2023, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there is no deviation or variation in the use of proceeds, during the quarter ended March 31, 2023. Enclosed please find the Statement as per the format, giving details of the same.

pdf

GKB Ophthalmics Ltd.

30 May 2023

69.80

-0.11%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Intimation Under Regulation 30 Of SEBI ( Listing Obligations And …

BSE India

Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Kulkarni and Bhat, Chartered Accountants ( Firm Registration No. 115960W), Internal Auditors of the Company, have have expressed their intent to resign from the post of Internal Auditor of the Company, from F.Y. 2023-24 onwards, due to professional engagements. The Audit Committee and Board of Directors of the Company have accepted the resignation at their respective meetings held on May 30, 2023. Also, as per the recommendation of the Audit Committee at its meeting held on May 30, 2023, the Board of Directors have considered and approved the appointment of RRK & Co.,Chartered Accountants as Internal Auditors of the Company. Details with respect to the change of Internal Auditors in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 is also annexed herewith.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%